5 Treatment and prognostic factors in acute myeloid leukaemia

This publication has 57 references indexed in Scilit:

• Granulocyte‐Macrophage colony stimulating factor (GM‐CSF) priming in the treatment of elderly patients with acute myelogenous leukemia
  American Journal of Hematology, 1995
• Interleukin-2 Bolus Infusion as Late Consolidation Therapy in 2nd Remission of Acute Myeloblastic Leukemia
  Leukemia & Lymphoma, 1995
• Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors
  British Journal of Haematology, 1994
• Interleukin 2 treatment in acute myelogenous leukemia
  The International Journal of Cell Cloning, 1993
• Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
  The Lancet, 1993
• Role of Interleukin-1 Inhibitory Molecules in Therapy of Acute and Chronic Myelogenous Leukemia
  Leukemia & Lymphoma, 1993
• Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by Cyclosporine
  JNCI Journal of the National Cancer Institute, 1990
• The frequency of long‐term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow‐up time of 6 years
  British Journal of Haematology, 1989
• Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia
  European Journal of Cancer and Clinical Oncology, 1987
• Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide
  New England Journal of Medicine, 1986